MedTrace Logo

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

NCT03039634 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2019-03-04

No results posted yet for this study

Summary

This study evaluates the safety, effectiveness, and maintenance of effect of a novel topical silver particle solution (Sienna 755.1100, 810.1100, or 1064.1100) used in conjunction with a laser for the treatment of Acne Vulgaris.

Conditions

  • Acne Vulgaris

Sponsors & Collaborators

  • Sienna Labs

    lead INDUSTRY

Principal Investigators

  • Paul Lizzul, MD · Sienna Biopharmaceuticals

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03039634 on ClinicalTrials.gov